狂野欧美激情性xxxx欧美I 成人性生交大片免费看中文网站I 日韩视频一区二区在线I 国产中的精品av小宝探花I 黄色国产在线I 久久精品视频在线观看I 在线天堂8√

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > pFH154
最近瀏覽歷史
聯(lián)系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮(zhèn)海區(qū)莊市街道興莊路9號
  • 創(chuàng)e慧谷42號樓B幢401室
pFH154
pFH154
規(guī)格:
貨期:
編號:B206497
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規(guī)格:
凍干粉
斜面
甘油
平板


產(chǎn)品名稱 pFH154
商品貨號 B206497
Designations pFH154
GenBank Number

X02761

Species Homo sapiens, human
Depositors FE Baralle
Vector
Construct size (kb): 6.5
Insert
DNA: cDNA
Insert lengths(kb): 2.5
Tissue: Hs578T cell line
Gene product: fibronectin 1 [FN1]
Alleles: A2, E2, A1, B2, D2, B1, D1, E1
Insert Size (kb) 2.5
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Shipping Information Distributed: DNA (dried). Rehydrate with TE. (amount: 200 ng)
Comments
Restriction digests of the clone give the following sizes (kb): PvuII--5.3, 0.7; HindIII--6.1; BamHI--4.8, 1.4; HindIII/BamHI--3.4, 1.4 (doublet); EcoRI--4.8, 1.5.
Waldenburg syndrome shows close linkage to FN1 and ALPP in one multigenerational family with 11 affected individuals.
References

Kornblihtt AR, et al. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J. 4: 1755-1759, 1985. PubMed: 2992939

Asher JH Jr., et al. Waardenburg syndrome (WS): the analysis of a single family with a WS1 mutation showing linkage to RFLP markers on human chromosome 2q. Am. J. Hum. Genet. 48: 43-52, 1991. PubMed: 1670751

Gardella R, et al. A common MspI RFLP of the human fibronectin gene (FN1). Nucleic Acids Res. 16: 1651, 1988. PubMed: 2450335

梅經(jīng)理 17280875617 1438578920
胡經(jīng)理 13345964880 2438244627
周經(jīng)理 17757487661 1296385441
于經(jīng)理 18067160830 2088210172
沈經(jīng)理 19548299266 2662369050
李經(jīng)理 13626845108 972239479
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |